This is critical, as human mutations in the CaM binding interface of NaV1.5 are linked to LQT3 (14), although augmentation of late Na+ current is likely not the main pathophysiological mechanism responsible for the LQTS phenotype observed in patients with CaM mutations (39). The gene discussed is SCN5A; the disease is long QT syndrome 3.